Phase 3 prospective, multicenter, open label study to investigate safety, immunogenicity and hemostatic efficacy, of PEGylated Factor VIII (BAX855) in previously untreated patients (PUPs) <6 years with severe hemophilia A (FVIII<1%) | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

Phase 3 prospective, multicenter, open label study to investigate safety, immunogenicity and hemostatic efficacy, of PEGylated Factor VIII (BAX855) in previously untreated patients (PUPs) <6 years with severe hemophilia A (FVIII<1%)

KOÇ ŞENOL S. B.

Diğer Uluslararası Fon Programları, 2017 - Devam Ediyor

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Ocak 2017
Bitiş Tarihi: Devam Ediyor